Skip to main content
SpringerLink
Log in

SGLT2 inhibitor/GLP-1 receptor agonists as first step monotherapy—evidence and implications

  • Letter to the Editor
  • Published:
International Journal of Diabetes in Developing Countries Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Cosentino F, Grant PJ, Aboyans V, Bailey CJ, Ceriello A, Delgado V, et al. ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the task force for diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and the European Association for the Study of Diabetes (EASD). Eur Heart J. 2019:ehz486. https://doi.org/10.1093/eurheartj/ehz486.

  2. Eurich DT, McAlister FA. Wrongfully accused: metformin use in heart failure. Expert Rev Cardiovasc Ther. 2011 Feb;9(2):147–50.

    Article  CAS  Google Scholar 

  3. Aguilar D, Chan W, Bozkurt B, Ramasubbu K, Deswal A. Metformin use and mortality in ambulatory patients with diabetes and heart failure. Circ Heart Fail. 2011 Jan;4(1):53–8.

    Article  CAS  Google Scholar 

  4. Roumie CL, Chipman J, Min JY, Hackstadt AJ, Hung AM, Greevy RA Jr, et al. Association of treatment with metformin vs sulfonylurea with major adverse cardiovascular events among patients with diabetes and reduced kidney function. JAMA. 2019 Sep;19:1–11. https://doi.org/10.1001/jama.2019.13206.

    Article  CAS  Google Scholar 

  5. Chawla R, Madhu SV, Makkar BM, Ghosh S, Saboo B, Kalra S. RSSDI-ESI clinical practice recommendations for the management of type 2 diabetes mellitus 2020. IJEM. 2020;24(1):1–122.

    PubMed  Google Scholar 

  6. Lavalle-González FJ, Januszewicz A, Davidson J, Tong C, Qiu R, Canovatchel W, et al. Efficacy and safety of canagliflozin compared with placebo and sitagliptin in patients with type 2 diabetes on background metformin monotherapy: a randomised trial. Diabetologia. 2013;56(12):2582–92. https://doi.org/10.1007/s00125-013-3039-1.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Affairs and Clinical Research Department, Ipca Laboratories Limited, Mumbai, Maharashtra State, 400067, India

    Anil Pareek, Ravi T. Mehta & Shruti Dharmadhikari

Authors
  1. Anil Pareek
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Ravi T. Mehta
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Shruti Dharmadhikari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Anil Pareek.

Ethics declarations

Conflict of interest

Authors are employees of Ipca Laboratories Limited which markets anti-diabetic drugs

Research involving human participants and/or animals

This manuscript did not involve participation of human volunteers or animal as this is a letter to the editor (comment on the guideline)

Informed consent

This manuscript did not require participation of humans and hence informed consent was not required as this is a letter to the editor (comment on the guideline)

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Pareek, A., Mehta, R.T. & Dharmadhikari, S. SGLT2 inhibitor/GLP-1 receptor agonists as first step monotherapy—evidence and implications. Int J Diabetes Dev Ctries 40, 636–637 (2020). https://doi.org/10.1007/s13410-020-00833-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s13410-020-00833-4

Search

Navigation